Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Oslo Bors  >  Photocure ASA    PHO   NO0010000045

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Develops and sells pharmaceuticals and medical devices

Photocure ASA engages as a pharmaceutical company, which engages in the provision of photodynamic diagnosis and treatment.

It operates through Commercial Franchise and Development Portfolio segments.

The Commercial Franchise segment includes Hexvix/Cysview products and is broken down into own and partner sales.

The Development Portfolio segment offers development of commercial products and pipeline
products.

The company was founded on August 27, 1993 and is headquartered in Oslo, Norway.

Number of employees : 49 persons.
Sales per Businesses
20142015Delta
NOK (in Million)%NOK (in Million)%
Cancer92.0171.4%---
Dermatology1.571.2%---
Commercial Franchise--134.72100%-
Sales per Regions
20142015Delta
NOK (in Million)%NOK (in Million)%
Partner Countries Europe47.8937.1%60.6545% +26.63%
Nordic Countries33.4225.9%38.6728.7% +15.72%
United States12.289.5%23.0217.1% +87.47%
Managers
NameAgeSinceTitle
Kjetil Hestdal MD, PhD561997President, Chief Executive Officer & Media Contact
Bente-Lill Bjerkelund Romøren672014Chairman
Kathleen Deardorff, PhD572011Chief Operating Officer & IR Contact
Erik Dahl-2012Chief Financial Officer & IR Contact
Inger Ferner Heglund612006Vice President-Research & Development
Xavier Denis Yon762011Independent Director
Synne Hermansen Røine, MBA372014Independent Director
Tom Edward Pike56-Independent Director
Lars Rønn52-Independent Director
Grete Hogstad602005Vice President-Strategic Marketing
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 21,476,295 16,553,760 77.1% 809 0.0% 77.1%
Shareholders
NameEquities%
Hunter Hall Investment Management Ltd. 2,957,334 13.8%
KLP Kapitalforvaltning AS 2,217,165 10.3%
Alexander Brask Hansson 2,150,000 10.0%
Fondsfinans Kapitalforvaltning ASA 2,054,371 9.57%
Radiumhospitalets Forskningsstiftelse 2,029,000 9.45%
Danske Capital AS 859,851 4.00%
MP Pensjon PK 850,000 3.96%
Skagen AS 626,466 2.92%
DNB Asset Management AS 529,060 2.46%
Bergen Kommunale Pensjonskasse 500,000 2.33%
Holdings
NameEquities%Valuation
PCI Biotech Holding ASA (PCIB) 1,726,00411.6%1,382,546 USD
Photocure ASA (PHO) 32,4760.15%159,308 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals
Growth (Revenue) Profitability
JOHNSON & JOHNSON
ROCHE HOLDING LTD..
NOVARTIS AG
PFIZER INC.
MERCK & CO., INC.
BRISTOL-MYERS SQU..
NOVO NORDISK A/S
SANOFI
GLAXOSMITHKLINE P..
ALLERGAN PLC
ELI LILLY AND CO
BAYER AG
ASTRAZENECA PLC
ABBOTT LABORATORI..
TEVA PHARMACEUTIC..
-
SHIRE PLC
TAKEDA PHARMACEUT..
ASTELLAS PHARMA I..
MYLAN NV
CHUGAI PHARMACEUT..
Sector Pharmaceuticals
Photocure ASA : Connections
Acd Pharmaceuticals AS
Radiumhospitalets Forskningsstiftelse
Vaccibody AS
Credio as
Chester Valley Pharmaceuticals, Inc.
Clinique des Champs Elysees
Colosseum Smile Group AB
Goapharma SAS
Michelson Diagnostics Ltd.
ClanoTech AB
Medical Instill Technologies, Inc
Europharma Apotek AS
Pressalit A/S
Biosergen AS
Laboratoires Panpharma SA
Elastagen Pty Ltd.
Triax A/S
Company contact information
Photocure ASA
Hoffsveien 4
Oslo 0275

Phone : +47.22.06.22.10
Fax : +47.22.06.22.18
Web : www.photocure.com
© 2016 People , Fundamentals and Ownership